Dabigatran etexilate Completed Phase 4 Trials for Nonvalvular Atrial Fibrillation Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01493557A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial Fibrillation
NCT01706146Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring